Canopy Growth(US:CGC) ZACKS·2025-10-30 22:50Core Insights - Canopy Growth Corporation's stock closed at $1.22, reflecting a decline of 2.4% from the previous day, underperforming compared to the S&P 500's loss of 0.99% [1] - The stock has decreased by 9.42% over the past month, contrasting with the Medical sector's gain of 6.65% and the S&P 500's gain of 3.59% [1] Earnings Performance - Canopy Growth is expected to announce its earnings on November 7, 2025, with a forecasted EPS of -$0.11, indicating an 88.42% improvement from the same quarter last year [2] - Revenue is projected to be $52.34 million, representing a 13.34% increase compared to the corresponding quarter of the previous year [2] - For the entire fiscal year, earnings are estimated at -$0.5 per share and revenue at $219.38 million, reflecting changes of +83.22% and +13.49% respectively from the prior year [3] Analyst Estimates - Changes in analyst estimates for Canopy Growth are crucial as they reflect the evolving nature of near-term business trends, with positive revisions indicating analysts' confidence in the company's performance [4] - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), has Canopy Growth currently rated at 3 (Hold), with the consensus EPS estimate remaining unchanged over the last 30 days [6] Industry Context - The Medical - Products industry, part of the Medical sector, holds a Zacks Industry Rank of 147, placing it in the bottom 41% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]